These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19787003)

  • 1. Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer.
    Panchal S; Shachar O; O'Malley F; Crystal P; Escallon J; Crook J; Bane A; Bordeleau L
    Nat Rev Clin Oncol; 2009 Oct; 6(10):604-7. PubMed ID: 19787003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
    Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS
    Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
    Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
    Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
    Obdeijn IM; Mann RM; Loo CCE; Lobbes M; Voormolen EMC; van Deurzen CHM; de Bock G; ; Hooning MJ
    Breast Cancer Res Treat; 2020 Jun; 181(3):581-588. PubMed ID: 32333294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological study of non-palpable familial breast cancer detected by screening mammography and diagnosed as DCIS.
    Saito M; Matsuzaki M; Sakuma T; Katagata N; Watanabe F; Yamaguchi Y; Schetter AJ; Takenoshita S; Nomizu T
    Breast Cancer; 2014 Mar; 21(2):140-5. PubMed ID: 22875640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectations of Surveillance for Non-BRCA Gene Mutation Carriers at Increased Risk for Breast Cancer.
    Caskey R; Singletary B; Ayre K; Parker C; Krontiras H; Lancaster RB
    J Surg Res; 2020 Dec; 256():267-271. PubMed ID: 32712440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer.
    Singer CF; Rappaport-Fuerhauser C; Sopik V; Narod SA
    Clin Genet; 2015 Aug; 88(2):187-9. PubMed ID: 25112434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
    Petridis C; Arora I; Shah V; Megalios A; Moss C; Mera A; Clifford A; Gillett C; Pinder SE; Tomlinson I; Roylance R; Simpson MA; Sawyer EJ
    Breast Cancer Res; 2019 May; 21(1):58. PubMed ID: 31060593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
    Riedl CC; Luft N; Bernhart C; Weber M; Bernathova M; Tea MK; Rudas M; Singer CF; Helbich TH
    J Clin Oncol; 2015 Apr; 33(10):1128-35. PubMed ID: 25713430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
    Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
    Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACCIDENTAL FINDING OF SYNCHRONOUS BILATERAL DUCTAL CARCINOMA IN SITU IN A YOUNG MAN REFERRED TO MASTECTOMY DUE TO GYNECOMASTIA - AND WHAT IF LIPOSUCTION HAVE BEEN USED? CASE REPORT.
    Horta R; Schmitt F; Pereira N; Gervásio H
    Acta Chir Plast; 2020; 62(1-2):46-49. PubMed ID: 32911942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ--management update.
    Stuart K; Boyages J; Brennan M; Ung O
    Aust Fam Physician; 2005 Nov; 34(11):949-54. PubMed ID: 16299630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ in BRCA mutation carriers.
    Hwang ES; McLennan JL; Moore DH; Crawford BB; Esserman LJ; Ziegler JL
    J Clin Oncol; 2007 Feb; 25(6):642-7. PubMed ID: 17210933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies.
    Silverstein MJ; Parker R; Grotting JC; Cote RJ; Russell CA
    J Am Coll Surg; 2001 Feb; 192(2):196-214. PubMed ID: 11220720
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
    Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
    Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.